Who is sponsoring NCT07356206?

NCT07356206 is sponsored by University of Minho.

What drugs are being tested in NCT07356206?

Interventions in NCT07356206: Behavioral: Dog Assisted Therapy (DAT - "Between Paws and Affections"), Behavioral: Psychoeducation and Relaxation without Dogs (Control).

What condition does NCT07356206 study?

NCT07356206 studies Fibromyalgia (FM).

Is NCT07356206 still recruiting?

NCT07356206 is currently active, enrolled. Last updated 21 January 2026.

Last reviewed 2026-01-21 · How we verify

NCT07356206: IDAT26

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Between Paws and Affections - Impact of Dog-Assisted Therapy in Fibromyalgia Patients

Active, enrolled NA Last updated 21 January 2026

What this trial tests

NA trial testing Behavioral: Dog Assisted Therapy (DAT - "Between Paws and Affections") in Fibromyalgia (FM) in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 December 2025

Primary endpoint
30 June 2028

30 June 2029

Quick facts

Lead sponsor	University of Minho
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	2 December 2025
Primary completion	30 June 2028
Estimated completion	30 June 2029
Sites	1 location across Portugal

Drugs / interventions tested

Behavioral: Dog Assisted Therapy (DAT - "Between Paws and Affections")
Behavioral: Psychoeducation and Relaxation without Dogs (Control)

Conditions studied

Fibromyalgia (FM) — all drugs for Fibromyalgia (FM) →

Sponsor

University of Minho

Who can join

18 and older, any sex, with Fibromyalgia (FM). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the effectiveness and medium-term maintenance of a structured dog-assisted therapy (DAT) protocol, "Entre Patas e Afetos" (Between Paws and Affections), in reducing pain, anxiety and depressive symptoms and in improving functional status and quality of life in Portuguese patients with fibromyalgia (FM) followed at ULS Alto Ave, with systematic outcome assessment in the immediate post intervention phase (T2), 6-month follow-up (T3) and 12-month follow-up (T4).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fibromyalgia (FM)

Currently open trials in the same condition.

NCT07361328 — Personalized Ultrasonic Brain Stimulation for Fibromyalgia · NA · recruiting
NCT07282392 — Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET) · NA · recruiting
NCT06813352 — Analysis of Facial Expressions for Pain Recognition in Fibromyalgia: Using Artificial Intelligence and Biomarkers · recruiting
NCT07074275 — Chronic Fibromyalgia Pain, Lifestyle Factors, and Inflammation · active not recruiting
NCT06880653 — Dose Response of Exercise for Arthritis Management · NA · recruiting

Other University of Minho trials

Trials by the same sponsor.

NCT07400978 — An At-distance and Online Intervention to Promote Parental Involvement and Self-regulation · NA · active not recruiting
NCT06050486 — A Mentalization-based Intervention for Children of Parent(s) With Borderline Personality Disorder · NA · active not recruiting
NCT05946083 — The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning · Phase 2 · recruiting
NCT05395364 — A Health Promotion Intervention for Vulnerable School · NA · completed
NCT04247516 — A Study Protocol for an Online Intervention to Promote School Engagement · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07356206 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minho
Last refreshed: 21 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07356206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing